인쇄하기
취소

Positive list system discourages new drug development projects

Published: 2008-05-15 06:59:00
Updated: 2008-05-15 06:59:00
Domestic pharmaceutical companies are in dilemma to cope with the current drug pricing system, called a positive list system, according to a top official of a domestic pharmaceutical firm.

In an information session, Chang An-Soo, president of Hanmi Pharm, said that the current pricing scheme has discouraged local pharmaceutical firms from developing new drugs due to red tape and the inconven...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.